SPECSHELL APS

Their core work

Specshell ApS is a Danish technology SME developing optical spectroscopy-based sensors for automated, real-time process monitoring in starch-processing industries. Their core product enables continuous quality control on industrial production lines, replacing manual sampling with inline optical measurement. The company followed the classic SME Instrument path: a Phase 1 feasibility study (ENZEYE, 2019) confirmed the market and technical approach, then a Phase 2 grant (OptiSpec, 2019–2021) funded full product development and commercialization. Their work sits at the intersection of optical sensing hardware, signal processing, and industrial food/ingredient manufacturing.

What they specialise in

How they've shifted over time

Specshell's entire H2020 record falls within 2019, so there is no multi-year trajectory to trace — the two projects represent a single, sequential development effort rather than an evolution of focus. The ENZEYE Phase 1 study and the OptiSpec Phase 2 project share identical problem framing, suggesting the company entered the EU funding system with a mature concept and used it instrumentally to accelerate one product to market. Without projects before or after this window, it is impossible to determine whether they have since broadened their application focus beyond starch processing.

Based on available data, Specshell appears to be a single-product deep-tech SME that used EU SME Instrument funding to commercialize one specific technology — further direction depends entirely on whether OptiSpec resulted in a market-ready product and whether they have since expanded to adjacent industries such as dairy, brewing, or pharma process control.

How they like to work

Specshell has coordinated both of its H2020 projects independently, with no recorded consortium partners — a pattern consistent with SME Instrument grants, which are designed for single companies developing their own proprietary technology. This means Specshell is not a natural consortium partner in the traditional sense; they build and own their product rather than co-developing with research institutions. Anyone approaching them for collaboration should expect an industrial partner relationship rather than an open research collaboration.

Specshell has no recorded H2020 consortium partners, which is structurally expected given the SME Instrument scheme they used. Their network within EU-funded research is effectively a network of one — they have operated as a solo applicant and technology developer throughout their H2020 participation.

What sets them apart

Specshell is one of a small number of companies specifically targeting the starch processing sector with inline spectroscopy — a niche application where general-purpose process analyzers often fail due to the physical and chemical properties of starch slurries. Their Phase 2 funding of €1.6M signals that EU evaluators validated both the technology readiness and the commercial case. For any company in starch, glucose syrup, modified starch, or related carbohydrate processing looking for a real-time quality monitoring solution, Specshell is a directly relevant technology provider rather than a generic instrumentation vendor.

Highlights from their portfolio

• OptiSpec
  The largest grant (€1.6M under SME-2) represents a fully validated commercial development project — EC funding at this level requires demonstrated market potential and a credible path to revenue.
• ENZEYE
  The Phase 1 feasibility study that preceded OptiSpec; the fact that it led directly to a Phase 2 award confirms the technical and market case was judged credible by independent EU evaluators.